Ionis Pharmaceuticals, Inc. (IONS)
74.54
+1.00
(+1.37%)
USD |
NASDAQ |
Jun 09, 16:00
74.54
0.00 (0.00%)
After-Hours: 17:52
Ionis Pharmaceuticals SG&A Expense (Quarterly) : 150.36M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Biogen, Inc. | 607.30M |
| BioMarin Pharmaceutical, Inc. | 258.30M |
| BridgeBio Pharma, Inc. | 163.90M |
| Mirum Pharmaceuticals, Inc. | 96.33M |